주메뉴 바로가기
서브메뉴 바로가기
본문 바로가기
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15
R&D
Laboratory
Pipeline
Technology
IR
IR Resource
Public Disclosures
Public Disclosures
PR
Notice
News
Materials
Careers
Talents
Welfare
Recruitment
KOR
ENG
Goldmmune
TEL
menu open
VaxcellBio, Inc.
KOR
ENG
menu close
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15 for Companion Animals
R&D
Laboratory
Pipeline
Technology
IR
Public Disclosures
Careers
Talents
Welfare
Recruitment
ⓒ VaxCell Biotherapeutics Co., Ltd.
PR
Notice
News
Materials
Notice
•
홈
> PR >
Notice
[보도자료] '진행성 췌장암' 첨단재생의료 임상연구 승인…화순전남대병원과 박셀바이오가 손잡고 진행
관리자
2025. 02. 03. 09:56
ref.
395
2025년 2월 3일 발행된 보도자료입니다.
•
[보도자료 2025-02-03] \'진행성 췌장암\' 첨단재생의료 임상연구 승인…화순전남대병원과 박셀바이오가 손잡고 진행.pdf
(Down: 69)
(Size: Byte)
•
[PRESS RELEASE 2025-02-03] Vaxcellbio’s NK Cell Therapy Approved for Advanced Pancreatic Cancer Clinical Study.pdf
(Down: 34)
(Size: Byte)
Prev:
[주주공지] VCB-1102 '진행성 췌장암' 첨단재생의료 임상연구 승인
Next:
List